Skip to main content
Join CMKC members for a complimentary virtual event on December 10, 11am ET: CM MythBusters: https://bit.ly/3YXJynA. This is a fantastic opportunity to connect, collaborate, and debunk common myths about continuous manufacturing!
18.218.76.193

Scaling continuous API synthesis from milligram to kilogram: extending the enabling benefits of micro to the plant

By Berton, M; de; Souza, JMAbdiaj, I; McQuade, DT; Snead, DR

Published on

Abstract

The signature benefits of continuous flow are largely a result of a reactor's micro-sized features. However, as the technology gains industrial traction in the synthesis of active pharmaceutical ingredients (API), the reactors must be scaled to larger size to meet production demands. Often, the micro-features cannot be preserved, and thus the challenge is in transferring the benefits of micro to the pilot plant and beyond. This review presents solutions to typical problems encountered in plug flow reactors (PFR) related to heat transfer, mixing, handling biphasic reactions, and photochemistry. Lessons are taken from kilogram level syntheses developed in pharmaceutical process chemistry groups.

Journal

Journal of Flow Chemistry. Volume 10, 2020, 73-92

DOI

10.1007/s41981-019-00060-x

Type of publication

Peer-reviewed journal

Affiliations

  • Virginia Commonwealth University
  • Universidade Federal de São Carlos

Article Classification

Review article

Classification Areas

  • API

Tags